Why SCRN is grossly undervaluedThe Corporation will acquire the CENTRED assets for an aggregate purchase price of CAD $13 million (the "Purchase Price"). The Purchase Price shall be satisfied through the issuance of common shares (the "Consideration Shares") of the Corporation at a deemed price of CAD $0.10 (the "Issue Price") or higher based on 10 day VWAP. The Consideration Shares shall be issued in stages based on defined milestones. One of the most significant being $3,000,000 that will be issued if fiscal 2022 net revenue is at least US$10,000,000.